Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for low-grade gliomas.

W P Mason1

  • 1Department of Medicine, University of Toronto and Princess Margaret Hospital, Toronto, Ontario, Canada.

Forum (Genoa, Italy)
|July 6, 2000
PubMed
Summary

Chemotherapy shows promise for low-grade gliomas, potentially delaying radiation. Further research is needed to confirm effectiveness, toxicity, and optimal agents for these brain tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.

European journal of cancer (Oxford, England : 1990)·2018
Same author

The views of patients with brain cancer about palliative care: a qualitative study.

Current oncology (Toronto, Ont.)·2017
Same author

Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma.

AJNR. American journal of neuroradiology·2013
Same author

Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme.

Current oncology (Toronto, Ont.)·2011
Same author

Canadian recommendations for the treatment of glioblastoma multiforme.

Current oncology (Toronto, Ont.)·2007
Same author

Radiation-induced glioma presenting as diffuse leptomeningeal gliomatosis: a case report.

Journal of neuro-oncology·2002

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Medical Oncology

Background:

  • Low-grade gliomas (oligodendrogliomas and oligoastrocytomas) management is complex.
  • Recent findings indicate potential chemosensitivity in these tumors.

Purpose of the Study:

  • To evaluate the role of chemotherapy in managing low-grade gliomas.
  • To assess the feasibility of delaying or avoiding cranial irradiation with chemotherapy.

Main Methods:

  • Review of preliminary results on chemotherapy response in low-grade oligodendroglial tumors.
  • Analysis of chemotherapy's impact compared to anaplastic counterparts.

Main Results:

  • Low-grade oligodendroglial tumors exhibit less predictable responses to chemotherapy than anaplastic tumors.
  • Chemotherapy offers potential for delaying or eliminating cranial irradiation.

Conclusions:

  • Chemotherapy presents an appealing initial treatment option for indolent gliomas.
  • Further research is essential to fully understand chemotherapy's efficacy, toxicity, and optimal use in low-grade gliomas, including correlation with molecular markers.

Related Experiment Videos